Management of patients with inflammatory bowel disease and outcomes during the first wave of the Covid-19 pandemic.
作者信息
Viola Anna, Giambò Federica, Chiappetta Michele Francesco, Costantino Giuseppe, Pallio Socrate, Fries Walter
机构信息
IBD-unit, Clinical Unit for Chronic Bowel Disorders, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
IBD-unit, Clinical Unit for Chronic Bowel Disorders, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
出版信息
Dig Liver Dis. 2021 Jun;53(6):689-690. doi: 10.1016/j.dld.2021.03.021. Epub 2021 Mar 27.
Abstract
摘要
相似文献
1
Management of patients with inflammatory bowel disease and outcomes during the first wave of the Covid-19 pandemic.炎症性肠病患者的管理以及新冠疫情第一波期间的治疗结果
Dig Liver Dis. 2021 Jun;53(6):689-690. doi: 10.1016/j.dld.2021.03.021. Epub 2021 Mar 27.
2
Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.炎症性肠病与 SARS-CoV-2 大流行：现有知识和建议。
Scand J Gastroenterol. 2021 Jun;56(6):656-660. doi: 10.1080/00365521.2021.1902561. Epub 2021 Mar 25.
3
Inflammatory Bowel Disease and the SARS-CoV-2 Pandemic: More Speed, Less Haste.炎症性肠病与新型冠状病毒肺炎大流行：更快行动，勿急行事。
Gastroenterology. 2021 Jan;160(1):473-474. doi: 10.1053/j.gastro.2020.05.013. Epub 2020 May 8.
4
Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.COVID-19 大流行期间炎症性肠病患者的实用管理：澳大利亚胃肠病学会炎症性肠病学院专家评论。
Intern Med J. 2020 Jul;50(7):798-804. doi: 10.1111/imj.14889.
5
The COVID-19 pandemic shows us in which way the care of patients with inflammatory bowel disease should move.新冠疫情让我们看到炎症性肠病患者的护理应该朝哪个方向发展。
Rev Esp Enferm Dig. 2021 Feb;113(2):153-154. doi: 10.17235/reed.2021.7765/2020.
6
Therapeutic Decisions in Inflammatory Bowel Disease in the SARS-Cov-2 Pandemic.2019冠状病毒病大流行期间炎症性肠病的治疗决策
Gastroenterology. 2021 Apr;160(5):1883-1884. doi: 10.1053/j.gastro.2020.05.083. Epub 2020 Jun 15.
7
Management of inflammatory bowel diseases in the wake of COVID-19 pandemic.新冠疫情之后炎症性肠病的管理
J Gastroenterol Hepatol. 2020 Aug;35(8):1449-1450. doi: 10.1111/jgh.15056. Epub 2020 Apr 26.
8
Establishing Safe Out-of-Hospital Infusion Centers May Improve the Quality of Care in Patients With IBD During the COVID-19 Pandemic.建立安全的院外输液中心可能会改善新冠疫情期间炎症性肠病患者的护理质量。
Inflamm Bowel Dis. 2020 Oct 23;26(11):e140. doi: 10.1093/ibd/izaa246.
9
Inflammatory Bowel Disease Management in a Major Referral Center During COVID-19 Pandemic.新冠疫情期间一家大型转诊中心的炎症性肠病管理
Inflamm Bowel Dis. 2020 Sep 18;26(10):e114-e115. doi: 10.1093/ibd/izaa204.
10
Low frequency of COVID-19 in inflammatory bowel diseases.炎症性肠病中新冠病毒病的低发病率
Dig Liver Dis. 2020 Nov;52(11):1234-1235. doi: 10.1016/j.dld.2020.06.007. Epub 2020 Jun 13.
引用本文的文献
1
Inflammatory bowel disease and COVID-19 outcomes: a meta-analysis.炎症性肠病与 COVID-19 结局：荟萃分析。
Sci Rep. 2022 Dec 9;12(1):21333. doi: 10.1038/s41598-022-25429-2.
2
Impact of COVID-19 pandemic on the healthcare and psychosocial well-being of patients with inflammatory bowel disease.2019年冠状病毒病大流行对炎症性肠病患者医疗保健及心理社会福祉的影响
Ann Gastroenterol. 2022 Mar-Apr;35(2):103-112. doi: 10.20524/aog.2022.0686. Epub 2022 Feb 10.
3
Delayed Infliximab Treatment Affects the Outcomes of Patients With Crohn's Disease During the COVID-19 Epidemic in China: A Propensity Score-Matched Analysis.在中国新冠疫情期间，英夫利昔单抗延迟治疗对克罗恩病患者结局的影响：一项倾向评分匹配分析
Front Med (Lausanne). 2022 Jan 12;8:819557. doi: 10.3389/fmed.2021.819557. eCollection 2021.
4
A Patient-Prioritized Agenda for Information Needs During the COVID-19 Pandemic: A Qualitative Study of Patients With Inflammatory Bowel Disease.新冠疫情期间患者优先的信息需求议程：一项针对炎症性肠病患者的定性研究
Crohns Colitis 360. 2021 Sep 19;3(4):otab066. doi: 10.1093/crocol/otab066. eCollection 2021 Oct.
Zotero 插件